Next Bt Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 11, 2022 at 03:05 am EST
Share
Next Bt Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 23,992.24 million compared to KRW 19,291.25 million a year ago. Net loss was KRW 517.96 million compared to KRW 1,026.92 million a year ago. Basic loss per share from continuing operations was KRW 6 compared to KRW 12 a year ago. Basic loss per share was KRW 6 compared to KRW 12 a year ago.
For the nine months, negative sales was KRW 0.00044 million compared to sales of KRW 0.0015 million a year ago. Net loss was KRW 5,691.74 million compared to KRW 13,670.99 million a year ago. Basic loss per share from continuing operations was KRW 64 compared to KRW 156 a year ago. Basic loss per share was KRW 64 compared to KRW 156 a year ago.
BL PharmTech Corp, formerly Next BT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of health foods. The Company operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.
BL PHARMTECH CORP. 
